- La FTC testifica ante el Subcomité de Comercio del Senado sobre los esfuerzos de la agencia para combatir las declaraciones fraudulentas y engañosas sobre productos para perder peso ( )
- Supplement Marketers Settle FTC Charges that “BrainStrong Adult” Memory Improvement Claims Are Deceptive ( )
- Company Settles FTC Charges that Head Lice Prevention Claims Were Deceptive ( )
- FTC Charges Green Coffee Bean Sellers with Deceiving Consumers through Fake News Sites and Bogus Weight Loss Claims ( )
- FTC Approves Final Consent Orders Settling Charges that Companies Deceptively Claimed Their Genetically Modified Nutritional Supplements Could Treat Diseases ( )
- FTC Staff: Missouri Should Consider Changing Physician Supervision Requirements for Advanced Practice Registered Nurses ( )
- FTC Announces Agenda, Panelists for Upcoming Seminar on Privacy Implications of Consumer Generated and Controlled Health Data ( )
- FTC Approves Final Order Settling Charges That Community Health Systems, Inc.’s Acquisition of Health Management Associates Inc. was Anticompetitive in Two Local Markets ( )
- FTC Puts Conditions on Akorn Enterprises’ Proposed Purchase of Hi-Tech Pharmacal ( )
- FTC Approves Final Consent Settling Charges that L’Occitane, Inc. Misled Consumers to Believe that Creams Could Slim Their Bodies ( )
- FTC Chairwoman Releases 2013 Annual Highlights ( )
- FTC Announces Agenda for March 20-21 Workshop Examining U.S. Health Care Competition Issues ( )
- FTC Staff Opinion: Rx Program Operated for the Benefit of Non-Profit Schools, Colleges, and Universities Appears to Fall within the NPIA Exemption to Robinson-Patman ( )
- FTC Staff Paper: State Legislators Should Carefully Evaluate Proposals to Limit Advanced Practice Registered Nurses’ Scope of Practice ( )
- FTC Approves Final Consent Settling Charges that Accretive Health Failed to Adequately Protect Consumers’ Personal Information ( )
- FTC Puts Conditions on Endo Health Solutions’ Acquisition of Boca Life Science Holdings ( )
- FTC Puts Conditions on Thermo Fisher Scientific Inc.’s Proposed Acquisition of Life Technologies Corporation ( )
- Provider of Medical Transcript Services Settles FTC Charges That It Failed to Adequately Protect Consumers’ Personal Information ( )
- Statement of FTC Chairwoman Edith Ramirez on the U.S. District Court in the District of Idaho Ruling in the Matter of the Federal Trade Commission and the State of Idaho v. St. Luke’s Health System Ltd. and Saltzer Medical Group, P.A. ( )
- FTC Staff: Massachusetts Should Consider Removing Physician Supervision Requirements for Nurse Practitioners and Nurse Anesthetists ( )
- FTC Requires Community Health Systems, Inc. to Divest Two Hospitals as a Condition of Acquiring Rival Hospital Operator ( )
- Accretive Health Settles FTC Charges That It Failed to Adequately Protect Consumers’ Personal Information ( )
- FTC Approves Final Order Settling Charges That Mylan, Inc.’s Acquisition of Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. Was Anticompetitive ( )
- FTC Approves Final Order Settling Charges that Actavis, Inc.’s Acquisition of Warner Chilcott plc Would Be Anticompetitive in Four Current and Future Drug Markets ( )
- FTC Announces Agenda for Workshop Examining Competition Issues Surrounding Biologic and Follow-on Biologic Medicines: Biosimilars and Interchangeables ( )
- FTC Staff Submits Comment to the Commission on Dental Accreditation Regarding its Proposed Standards for Dental Therapy Education Programs ( )
- FTC to Host Spring Seminars on Emerging Consumer Privacy Issues ( )
- FTC Chairwoman Ramirez Testifies Before House Judiciary Subcommittee on Agency’s Enforcement of U.S. Antitrust Laws to Promote Competition and Protect Consumers ( )
- FTC to Host Workshop on the Competitive Impacts of State Regulations and Naming Conventions Concerning Follow-on Biologics ( )
- FTC Finalizes Amendments to the Premerger Notification Rules Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical Industry ( )